Mibefradil reduces hepatic glucose output in HepG2 cells via Ca2+/calmodulin-dependent protein kinase II-dependent Akt/forkhead box O1signaling
Ying, Dai, Mengya, Shan, Peilin, Li, Lingong, Zhao, huan, Ma, Jing, Xu, Le, Zhang, Kebin, Zhang, Bin, Chen, Jun, Yan, Shaodong, Guo, Zihui, Xu
Published in European journal of pharmacology (15.09.2021)
Published in European journal of pharmacology (15.09.2021)
Get full text
Journal Article
Mibefradil reduces hepatic glucose output in HepG2 cells via Ca 2+ /calmodulin-dependent protein kinase II-dependent Akt/forkhead box O1signaling
Ying, Dai, Mengya, Shan, Peilin, Li, Lingong, Zhao, Huan, Ma, Jing, Xu, Le, Zhang, Kebin, Zhang, Bin, Chen, Jun, Yan, Shaodong, Guo, Zihui, Xu
Published in European journal of pharmacology (15.09.2021)
Get full text
Published in European journal of pharmacology (15.09.2021)
Journal Article